Tiziana Life Sciences (TLSA) Cash & Current Investments (2017 - 2025)
Tiziana Life Sciences (TLSA) posted quarterly Cash & Current Investments of $4.0 million for Q4 2025, up 7.68% year-over-year from $3.7 million in Q4 2024, and down 44.7% quarter-over-quarter from $7.3 million in Q2 2025.
Tiziana Life Sciences (TLSA) Cash & Current Investments (2017 - 2025) Analysis & Trends
Tiziana Life Sciences' Cash & Current Investments history runs 9 years deep, the most recent figure standing at $4.0 million for Q4 2025.
- In Q4 2025, Cash & Current Investments rose 7.68% year-over-year to $4.0 million; the TTM figure through Dec 2025 stood at $4.0 million (up 7.68% YoY), while the FY2025 annual figure was $4.0 million, up 7.68% from the prior year.
- Cash & Current Investments for Q4 2025 stood at $4.0 million, down from $7.3 million in the prior quarter.
- The five-year high for Cash & Current Investments was $54.0 million in Q2 2021, with the low at -$455000.0 in Q2 2024.
- The 5-year median for Cash & Current Investments is $7.0 million (2023), against an average of $16.4 million.
- The sharpest annual moves came in 2024 and 2025: Cash & Current Investments plunged 106.81% in 2024, then surged 1693.63% in 2025.
- Tiziana Life Sciences' Cash & Current Investments stood at $42.2 million in 2021, then plunged by 54.98% to $19.0 million in 2022, then plunged by 95.89% to $781000.0 in 2023, then surged by 376.82% to $3.7 million in 2024, then increased by 7.68% to $4.0 million in 2025.
- Business Quant data shows TLSA's Cash & Current Investments at $4.0 million in Q4 2025, $7.3 million in Q2 2025, and $3.7 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 7.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 5.18 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.14 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 3.31 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.39 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.16 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 836.99 Mn |
| 10 | Tiziana Life Sciences | 133.66 Mn | 129.65 Mn | - | 4.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.01 Mn |
| Jun 30, 2025 | 7.25 Mn |
| Dec 31, 2024 | 3.72 Mn |
| Jun 30, 2024 | -455,000.00 |
| Dec 31, 2023 | 781,000.00 |
| Jun 30, 2023 | 6.68 Mn |
| Dec 31, 2022 | 18.99 Mn |
| Jun 30, 2022 | 26.54 Mn |
| Dec 31, 2021 | 42.19 Mn |
| Jun 30, 2021 | 53.96 Mn |
| Dec 31, 2020 | 63.67 Mn |
| Jun 30, 2020 | 8.94 Mn |
| Dec 31, 2019 | 196,715.91 |
| Jun 30, 2019 | 572,409.12 |
| Dec 31, 2018 | 5.36 Mn |
| Jun 30, 2018 | 89,915.42 |
| Dec 31, 2017 | 63,727.91 |